Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

India’s Serum Novavax jab to be launched for children in six months

December 14, 2021 Medical Communications

The Serum Institute of India (SII) plans to launch the Novavax COVID-19 vaccine for children in the country in six …
News
astrazeneca_plaque

Samsung Biologics and AstraZeneca expand partnership to include COVID-19 and cancer therapy

December 14, 2021 Medical Communications

Contract development and manufacturing organisation (CDMO), Samsung Biologics, and AstraZeneca, continue their strategic collaboration which was initiated in May 2021. …
News
chris_hewitt_head_shot

Amarin appoints Dr Chris Hewitt UK and Ireland Medical Director

December 13, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Amarin has appointed Dr Chris Hewitt as UK and Ireland Medical Director. Hewitt is a UK-trained physician with many years …
Appointment

CDC authorise Pfizer boosters for 16- and 17-year-olds

December 10, 2021 Medical Communications

The FDA and CDC have authorised booster vaccinations of the Pfizer-BioNTech COVID-19 vaccine for teenagers aged 16 and 17. The …
News

FDA approves expansion for ZYNRELEF

December 10, 2021 Medical Communications

The FDA has approved Heron Therapeutics’ supplemental New Drug Application (sNDA) for ZYNRELEF (bupivacaine and meloxicam), to significantly expand the …
News

UK study shows Pfizer and Moderna jabs give best COVID-19 protection

December 3, 2021 Medical Communications

The Pfizer and Moderna booster vaccines have been shown to provide the best overall boost response, according to a UK …
News

WHO say Delta measures will help fight Omicron

December 3, 2021 Medical Communications

WHO officials have shared that COVID-19 health measures taken prior to the emergence of Omicron will also help combat the …
News

Researchers develop blood test for HPV-associated head and neck cancer

December 3, 2021 Medical Communications

A new blood test developed by researchers at Mass Eye and Ear and Mass General Hospital have developed a more …
News

ARASENS Phase III trial for prostate cancer treatment meets primary endpoint

December 3, 2021 Medical Communications

Orion and Bayer’s Phase III ARASENS trial has demonstrated an increase in overall survival, evaluating darolutamide in combination with docetaxel …
News

New COVID-19 variant in South Africa as massive surge in Europe infections

November 26, 2021 Medical Communications

A new variant of coronavirus found in South Africa is feared to be more transmissible than other strains, and poses …
News

Allorion gains $40 million funding to enhance and discover precision targets

November 26, 2021 Medical Communications

Allorion Therapeutics has announced that they have gained $40 million in Series A financing. The funding was led by Chinese …
News

Pfizer seek EUA for novel COVID treatment pill

November 19, 2021 Medical Communications

Pfizer is seeking FDA Emergency Use Authorisation (EUA) for the novel oral antiviral, Paxlovid. The pill, if authorised, will help …
News

ImmunityBio expands COVID-19 vaccine programme to incorporate ‘mix-and-match’ technologies

November 19, 2021 Medical Communications

Clinical-stage immunotherapy company, ImmunityBio Inc, has announced the expansion of the company’s cancer and infectious disease vaccine programmes to include …
News

FDA approve Keytruda as adjuvant treatment for kidney cancer

November 19, 2021 Medical Communications

The FDA has approved Keytruda® for the treatment of patients with early renal cell carcinoma at high or intermediate-high risk …
News
nice_reception_manc_3_2_1

NICE recommends at-home treatment for spinal muscular atrophy

November 19, 2021 Medical Communications

NICE has recommended risdiplam as treatment for the rare genetic disorder, spinal muscular atrophy, as part of a managed access …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025